BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29075000)

  • 1. Association between chemerin, omentin-1 and risk of heart failure in the population-based EPIC-Potsdam study.
    Menzel J; di Giuseppe R; Biemann R; Wittenbecher C; Aleksandrova K; Eichelmann F; Fritsche A; Schulze MB; Boeing H; Isermann B; Weikert C
    Sci Rep; 2017 Oct; 7(1):14171. PubMed ID: 29075000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omentin-1 and risk of myocardial infarction and stroke: Results from the EPIC-Potsdam cohort study.
    Menzel J; di Giuseppe R; Biemann R; Wittenbecher C; Aleksandrova K; Pischon T; Fritsche A; Schulze MB; Boeing H; Isermann B; Weikert C
    Atherosclerosis; 2016 Aug; 251():415-421. PubMed ID: 27298015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of novel adipokines, omentin-1 and chemerin, in patients with acute myocardial infarction: KOZANI STUDY.
    Kadoglou NP; Tahmatzidis DK; Giannakoulas C; Kapelouzou A; Gkontopoulos A; Parissis J; Lampropoulos S; Kottas G
    J Cardiovasc Med (Hagerstown); 2015 May; 16(5):341-6. PubMed ID: 25022935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum omentin-1 and chemerin concentrations in pancreatic cancer and chronic pancreatitis.
    Kiczmer P; Szydło B; Seńkowska AP; Jopek J; Wiewióra M; Piecuch J; Ostrowska Z; Świętochowska E
    Folia Med Cracov; 2018; 58(2):77-87. PubMed ID: 30467436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Omentin as a Novel Biomarker for Colorectal Cancer Risk: Data from the EPIC-Potsdam Cohort Study.
    Aleksandrova K; di Giuseppe R; Isermann B; Biemann R; Schulze M; Wittenbecher C; Fritsche A; Lehmann R; Menzel J; Weikert C; Pischon T; Boeing H
    Cancer Res; 2016 Jul; 76(13):3862-71. PubMed ID: 27216184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of chemerin, apelin, vaspin, and omentin-1 in obese type 2 diabetic Egyptian patients with coronary artery stenosis.
    Motawi TMK; Mahdy SG; El-Sawalhi MM; Ali EN; El-Telbany RFA
    Can J Physiol Pharmacol; 2018 Jan; 96(1):38-44. PubMed ID: 28957639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of circulating chemerin and omentin levels with Th17 and Th9 cell immune responses in patients with asthma.
    Zhou Q; Fu Y; Hu L; Li Q; Jin M; Jiang E
    J Asthma; 2018 Jun; 55(6):579-587. PubMed ID: 28771382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of serum omentin-1 levels on cardiac prognosis in patients with heart failure.
    Narumi T; Watanabe T; Kadowaki S; Kinoshita D; Yokoyama M; Honda Y; Otaki Y; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Miyamoto T; Kubota I
    Cardiovasc Diabetol; 2014 Apr; 13():84. PubMed ID: 24755035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rhythmic aerobic exercise plus core stability training on serum omentin, chemerin and vaspin levels and insulin resistance of overweight women.
    Faramarzi M; Banitalebi E; Nori S; Farzin S; Taghavian Z
    J Sports Med Phys Fitness; 2016 Apr; 56(4):476-82. PubMed ID: 25651894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of serum omentin-1 and chemerin with gestational diabetes mellitus].
    Pan BL; Ma RM
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Aug; 36(9):1231-1236. PubMed ID: 27687656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease.
    El-Mesallamy HO; El-Derany MO; Hamdy NM
    Diabet Med; 2011 Oct; 28(10):1194-200. PubMed ID: 21668495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome.
    Guvenc Y; Var A; Goker A; Kuscu NK
    J Int Med Res; 2016 Aug; 44(4):796-805. PubMed ID: 27225862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome.
    Jialal I; Devaraj S; Kaur H; Adams-Huet B; Bremer AA
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E514-7. PubMed ID: 23303213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease.
    Yilmaz Y; Yonal O; Kurt R; Alahdab YO; Eren F; Ozdogan O; Celikel CA; Imeryuz N; Kalayci C; Avsar E
    Scand J Gastroenterol; 2011 Jan; 46(1):91-7. PubMed ID: 20809771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Chemerin Plasma Concentration With Risk of Colorectal Cancer.
    Eichelmann F; Schulze MB; Wittenbecher C; Menzel J; Weikert C; di Giuseppe R; Biemann R; Isermann B; Fritsche A; Boeing H; Aleksandrova K
    JAMA Netw Open; 2019 Mar; 2(3):e190896. PubMed ID: 30901045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of omentin and chemerin in metabolic syndrome and tumor diseases.
    Szydło B; Kiczmer P; Świętochowska E; Ostrowska Z
    Postepy Hig Med Dosw (Online); 2016 Aug; 70(0):844-9. PubMed ID: 27516571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of omentin-1 and visfatin in senile patients with coronary heart disease and heart failure.
    Wang XH; Dou LZ; Gu C; Wang XQ
    Asian Pac J Trop Med; 2014 Jan; 7(1):55-62. PubMed ID: 24418084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome.
    Guzel EC; Celik C; Abali R; Kucukyalcin V; Celik E; Guzel M; Yilmaz M
    Gynecol Endocrinol; 2014 Jun; 30(6):419-22. PubMed ID: 24524360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating apelin, chemerin and omentin levels in patients with gestational diabetes mellitus: a systematic review and meta-analysis.
    Sun J; Ren J; Zuo C; Deng D; Pan F; Chen R; Zhu J; Chen C; Ye S
    Lipids Health Dis; 2020 Feb; 19(1):26. PubMed ID: 32087711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes.
    Kukla M; Menżyk T; Dembiński M; Winiarski M; Garlicki A; Bociąga-Jasik M; Skonieczna M; Hudy D; Maziarz B; Kusnierz-Cabala B; Skladany L; Grgurevic I; Wójcik-Bugajska M; Grodzicki T; Stygar D; Rogula T
    Sci Rep; 2021 Nov; 11(1):21514. PubMed ID: 34728695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.